Drug profile · INN
florbetapir f-18
AMYVID
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
florbetapir f-18 (AMYVID) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN florbetapir f-18
Brand AMYVID
Route INTRAVENOUS
Formulation SOLUTION
Frequently asked questions
What is florbetapir f-18?
florbetapir f-18 (AMYVID) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for florbetapir f-18?
AMYVID is a marketed brand name for florbetapir f-18. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of florbetapir f-18?
florbetapir f-18 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.